{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Bromocriptine Mesylate, sold under the brand name PARLODEL, is an oral prescription drug manufactured by ANI Pharmaceuticals, Inc. It comes in tablet form (2.5 mg) and capsule form (5 mg) for treating conditions like Parkinson's disease and high prolactin levels. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Bromocriptine mesylate \u2014 ANDA 077646 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077646", "mediaType": "text/html", "title": "Bromocriptine mesylate"}], "identifier": "ANDA077646", "issued": "2016-09-16", "keyword": ["health-care", "medications", "pharmaceuticals", "prescription-drugs", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Bromocriptine mesylate"}